The original content of Democracy Now! Headlines appears under the Creative
Commons BY-NC-ND 3.0 License (United States). For more, including their other
shows and media, visit www.democracynow.org.
April 21, 2021

Johnson & Johnson Resumes European Rollout After Regulator Says Benefits Outweigh Blood Clot Risk
-------------------------------------------------------------------------------------------------

Johnson & Johnson is resuming its rollout in Europe after the EU drugs
regulator said the vaccine may be linked to extremely rare blood clots
but that its benefits far outweigh its risks. The European regulator
said the vaccine should carry a warning. It will be up to individual EU
countries to decide whether and how to distribute the J&J vaccine. On
Friday, a panel for the Centers for Disease Control and Prevention will
meet to make recommendations on its use in the U.S., which has been
temporarily halted.


.